Johannes R Kratz

2PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 17, 2026
Beyond Major Pathologic Response in Lung Cancer: Biomarkers Predict Outcomes.

|Jul 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.

Collin M Blakely, Anatoly Urisman, Matthew A Gubens

Pageof 1